Between June 2016 and October 2018, 117 stage IV lung EGFR mutant adenocarcinoma patients were retrieved and analyzed; Figure 1 summarizes the way that the patients were recruited in this study. The gene discussed is EGFR; the disease is adenocarcinoma.